Introduction
Pseudogenes are usually considered functionally inactive copies of genes, although their number probably exceeds that of the latter (Torrents et al., 2003; Zhang et al., 2003) . They may originate from reverse transcription of normal mRNA transcripts and hence are called processed pseudogenes, or alternatively they may result from gene duplication and are called nonprocessed pseudogenes (Mighell et al., 2000) . Processed pseudogenes arise by retrotransposition, and are thus intronless and present direct repeats up-and downstream. Pseudogenes usually accumulate a variety of genetic alterations including deletions, insertions and frameshifts comparatively to their normal paralogs, which precludes them from being expressed into functional proteins.
Nevertheless, many exceptions exist where a pseudogene is transcribed and even translated into an active product (McCarrey, 1990; Sorge et al., 1990; Renaudie et al., 1992; Chakrabarti et al., 1995; Sun et al., 1998; Thiele et al., 2000) . It is increasingly suggested that the pseudogene category of genes might represent a reservoir for organisms and cells to use in 'emergency' situations such as environmental stress or under mutating conditions . Pseudogenes have also recently been shown to be associated with tumorigenesis (Tanooka et al., 1998; Zhang et al., 2000; Puget et al., 2002) .
Gap junctions are specialized structures involved in direct cell-cell communication, and are made of hemichannels (or connexons) composed of hexamers of proteins referred to as connexins (Cxs). They are involved in the intercellular coordination via the exchange of small cytoplasmic molecules. Connexins are important regulators in the context of normal development, metabolism, cell growth and other processes. Their mutations have also been associated with various human diseases (Bergoffen et al., 1993; BritzCunningham et al., 1995; Kelsell et al., 1997) . Also, it is increasingly evident that connexins are involved in cancer (Vine and Bertram, 2002) . In particular, connexins' role in breast cancer is under scrutiny (Carystinos et al., 2001) .
Many Cxs have been discovered so far, and Cx43 is the most studied because of its widespread expression. We have shown that Cx43 expression is lost in breast cancer tissues . Also, other studies strongly suggest a role of Cx43 in tumorigenesis (Hirschi et al., 1996; Cai et al., 1998) . We recently also reported that connexin expression can be regulated by the Ras-MAK kinase signaling pathway (Carystinos et al., 2003) .
Since the original study which identified and localized the human Cx43 pseudogene (CCx43), it has not been further characterized (Willecke et al., 1990) . To examine the expression and function of CCx43, we used differential RT-PCR and found CCx43 mRNA expression in various cell types. We further found that CCx43 can be translated in an in vitro translation system, and that a CCx43-green fluorescence protein (GFP) chimeric construct produced a fusion protein in transfected MCF-7 cells. Studies of the phenotype of CCx43-transfected NIH-3T3 cell line show that the CCx43 product inhibits cell growth without affecting GJIC.
Results

Cancer cell line-specific CCx43 expression
Sequence comparison of the open reading frames (ORFs) revealed the presence of an NcoI restriction site at position 605 from the ATG start site in the CCx43 predicted mRNA sequence, which is absent from the Cx43 counterpart. We took advantage of this feature to differentiate between the two transcripts. PCR products were therefore digested with NcoI and subjected to gel electrophoresis. Transcripts originating from CCx43 resulted in a 134-bp shorter fragment than the Cx43 transcripts. We investigated various cell lines for transcription of the CCx43. Interestingly, we found that unlike the normal mammary epithelial cells most of the cancer cell lines studied express CCx43 mRNA (Figure 1 ). For example, although various expression ratios were observed between the pseudogene and the paralogous Cx43 gene in the analysed breast cancer cell lines, in most of them the CCx43 appears to be expressed at significant level. Indeed, out of nine mammary breast cell lines (MCF-7, ZR-75-1, HBL-100, Hs578T, SKBR3, MDA-468, MDA-435, T47-D, MDA-MB-231), all but two (Hs578T and T47-D) showed CCx43 transcription. MDA-MB-231 cells show mainly the Cx43 transcript and a small fraction of the CCx43 transcript. None of the normal human mammary epithelial cells (NHMECs) analysed show any CCx43 transcription (result shown for one sample culture).
To rule out any artifactual transcription, we double purified mRNA using a first Trizol extraction (Invitrogen) followed by extensive DNase treatment (to exclude any possible amplification of genomic DNA template contaminant) and second purification using a High Pure RNA isolation kit (Roche), and we used different PCR conditions, varying the availability of primers and/or dNTPs (to exclude any competition effect between the two transcripts/templates) (data not shown). In addition, in the absence of the reverse transcription step in the amplification reactions of all RNA preparations, no PCR products were observed, further showing that no genomic DNA contamination was possibly the source of the CCx43 amplification products (data not shown). It is thus clear that the CCx43 is transcribed in various cell lines. Our screening of different cell lines also demonstrates pseudogene expression preferentially in breast cancer cells (Figure 1 ). This feature does not, however, seem to be exclusive to breast cancer cells, since we found a similar expression pattern in various other cancer cell types (data not shown).
Cx43 pseudogene 'promoter' analysis
Expression of mRNAs from processed pseudogenes requires a functional promoter. About the first 230 nucleotides from the 5 0 regulatory region of CCx43 are almost identical to the equivalent region of the functional Cx43 gene. As originally mentioned by Fishman et al. (1991) , and confirmed by computeraided search for transcription factor binding sites using the MatInspector program, there is a TATA-box-like element found at nucleotide -30 within the Cx43 promoter, while the same element exists at position À18 in the CCx43 upstream region (Fishman et al., 1991) . In addition, the observed expression of mRNAs from the Cx43 processed pseudogene is indicative of a promoter-like activity. This prompted us to test whether this transcriptional activity results from a promoter-like activity upstream of the starting ATG translation initiation site. Therefore, we first analysed 1 kb of its immediate 5 0 -flanking region in comparison with the 1 kb promoter region of the Cx43 gene, using the MatInspector software at a 95% stringency value (Genomatix). Several potential binding sites are located in the pseudogene upstream region (Figure 2a ). To test this region for any significant promoter activity, we cloned a 1 kb region upstream of CCx43 as well as the equivalent region from the Cx43 promoter. We then carried out a comparison of promoter strength by transfecting various cells with these promoter constructs. As illustrated by Figure 2b , surprisingly no promoter activity was observed within the first 1 kb proximal to the starting ATG in CCx43, when compared with the PGL3 basic vector or the Cx43 counterpart in MCF-7, a cell line that expresses CCx43 (Figure 1 ). The same result was obtained when transfecting other cells such as MDA-435 (data not shown). It is therefore possible that CCx43 transcription involves more complex mechanisms.
In vitro translation of the pseudogene
The fact that the predicted CCx43 ORF preserves its integral length suggested that it might be translated. We Figure 1 Expression of CCx43 in breast cancer cell lines. Total RNA was prepared from various cell lines and RT-PCR was carried out using oligonucleotides designed to amplify both Cx43 and CCx43 transcripts. The PCR products were digested with excess NcoI. The restriction fragments were analysed in a 1% agarose gel. Cx43-originating products are 600-bp long, while CCx43-originating ones yield distinguishable 465-bp-long fragments. As a control, all RT-PCR reactions were carried out in presence of GAPDH-specific oligonucleotides Human Connexin43 pseudogene expression M Kandouz et al generated constructs representing the complete putative coding sequence of CCx43 and the equivalent Cx43 sequence and analysed their translatability in a reticulocyte lysate-based in vitro transcription/translation assay. As shown in Figure 3a , the CCx43 coding plasmid was translated into a 43 kDa protein. Given the very high degree of homology between Cx43 and CCx43 on the basis of nucleotide sequences, we have not yet generated antibodies to detect each selectively, and it is very likely that some of the commercially available Cx43 antibodies recognize a CCx43 translation product. A corollary is the likelihood that studies using the various available antibodies are actually detecting both proteins. Further confirming this hypothesis, the use of a commercial antibody in immunoblotting protein extracts from Cx43-and CCx43-transfected versus mock-transfected NIH/3T3 cells suggests that this antibody recognizes both translation products (Figure 4a inset).
Expression and localization of a CCx43-GFP fusion protein in cells
To determine whether the CCx43 could be translated in vivo, breast cancer MCF-7 cells, which we found to naturally express CCx43 transcripts (Figure 1 ), were transiently transfected with plasmids encoding for either the CCx43/GFP or Cx43/GFP fusion proteins or GFP only and examined microscopically. As shown in Figure 3b , the CCx43/GFP fusion protein is expressed in this cell line. Indeed, GFP alone is expressed as a diffuse fluorescent signal located throughout the cytoplasm. CCx43/GFP fusion-transfected cells show bright punctuate aggregates, similar to the pattern we observed ( Figure 3b ) and as previously reported for the Cx43/ GFP fusion proteins (Jordan et al., 1999; Laird et al., 2001) . A similar expression was observed by transfecting other cell lines (data not shown). Therefore, it is clear that CCx43 transcripts are translatable in vivo.
CCx43 inhibits cell growth
Since CCx43 is transcribed and translated in vitro as well as in vivo, we did preliminary studies of potential function. Previous studies showed that Cx43 inhibits cell growth (Yamasaki and Naus, 1996) . We therefore examined whether or not CCx43 could have a similar effect. The MTT assay showed that, like Cx43, CCx43 significantly inhibits the growth of NIH/3T3 cells ( Figure 4a ). This is further confirmed by colony formation assay in which the empty pcDNA3.1 vectortransfected NIH/3T3 cells (neoP1) formed multiple colonies of various sizes, while no colonies at all were observed in both the CCx43-(b4P1) or Cx43-transfected (a1P1) cells (Figure 4b ). These data suggest that not only is CCx43 expressed but also it retains similar inhibitory effects as Cx43.
GJIC assay by scrape-loading dye transfer in CCx43-expressing cells
To test the ability of CCx43 to establish functional GJICs, we used a scrape-loading method (El-Fouly et al., 1987) , where the Rhodamin Dextran (RD) dye is Promoter functional assay using about 1-kb-long genomic sequences upstream of the starting ATG signal connected to a luciferase reporter gene. MCF-7 cells were transfected with different reporter gene constructs and analysed for luciferase expression as described in 'Materials and methods'. To normalize the luciferase activity with regard to transfection efficiency, cotransfections were carried out with a Renilla luciferase-containing control plasmid (pRL-null). Reported activities were determined as the mean of three independent experiments (n ¼ 8). Error bars represent the standard deviation (s.d.)
Human Connexin43 pseudogene expression M Kandouz et al retained exclusively within the cells adjacent to a wound introduced into the cell layer, while the Lucifer Yellow (LY) dye intake is observed in these cells as well as neighboring communication efficient cells. CCx43-, Cx43-or mock-transfected NIH/3T3 cells were grown in six-well plates, scraped and loaded with a mixture of LY and RD. As shown in Figure 5 , the Cx43-transfected cells (a1P1), used as a positive control, showed a better communication than the mock-transfected cells (neoP1). There was no significant difference in the number of neighboring cells that took up the LY dye, between the CCx43-transfected (b4P1) and the mock-transfected cells. This indicates that the CCx43 product does not affect GJIC in the NIH/3T3 cells.
Discussion
The widespread belief regarding pseudogenes is that they are 'junk' DNA, since few of those studied are transcribed and even fewer are translated or functionally active. In addition, the biological relevance of pseudogene expression remains largely unexplored (McCarrey, 1990; Sorge et al., 1990; Renaudie et al., 1992; Chakrabarti et al., 1995; Thiele et al., 2000) .
Gap junctions are involved in the intercellular transit of small signaling molecules such as Ca 2 þ , inositol triphosphate and cAMP (Flagg-Newton and Loewenstein, 1979; Elfgang et al., 1995) . A gap junction channel is made of two juxtaposed hemichannels (connexons), made of proteins called connexins, at the cell surface of two neighboring cells. To date, Connexin43 (Cx43) is the most studied connexin and the only one for which a pseudogene has been reported (Willecke et al., 1990) . Since CCx43 has an intact ORF sequence and a TATAbox-like element at position À18 in the CCx43 upstream region (Fishman et al., 1991) , we reasoned that it has the potential to encode for an intact transcript and protein.
We investigated CCx43 potential expression by searching for pseudogene-derived transcripts in the mRNA population of various cell lines. Using RT-PCR, we found that many cell lines have transcripts originating from the CCx43 (Figure 1 ). Their amount is roughly the same as the Cx43 transcripts in most breast cancer cell lines analysed. However, it is not clear yet whether this transcription pattern has a causal significance in malignant transformation or is a secondary consequence of some other molecular event. It is interesting to point out that there are an increasing number of reports of pseudogenes being selectively expressed in a cell typespecific manner (McCarrey, 1990; Andrea and Walsh, 1995; Korneev et al., 1999; Boschan et al., 2002; Uechi et al., 2002) , which supports an active role for the transcribed pseudogenes.
Among the reports of pseudogenes being transcriptionally active, different mechanisms have been proposed for their acquisition of a functional promoter (Kleene and Mastrangelo, 1999; Moran et al., 1999; Boschan et al., 2002) . In order to investigate whether the 5 0 -flanking sequence retained by the pseudogene is responsible for transcriptional activation, we studied the 'promoter' strength of this 5 0 -flanking region, using a luciferase assay. A 1-kb-long region upstream of the CCx43 ORF was cloned in the PGL-3 basic vector and compared with an equivalent region from the Cx43 promoter. Interestingly, we did not detect any promoter activity within the 1-kb-long CCx43 5 0 -flanking region in CCx43-expressing MCF-7 cells (Figure 2b ) and NIH/ 3T3 cells (data not shown), suggesting a more complex model for its transcriptional activity. It is possible that the assayed region lacks sequences required for quantitative expression that might be encompassed by a more remote region. Also, although no transcriptional activity was observed with the luciferase assay, the hypothesis that CCx43 evolved a cell type-specific 'promoter' cannot be ruled out. Indeed, other elements could be involved such as the chromatin context or the presence of a regulatory sequence further upstream or downstream of the ORF.
Since CCx43 has an intact ORF, and thus the potential to encode for a full protein, we used an in vitro translation assay and found that the CCx43 transcripts are translatable in this system and produce a protein product with the same size as Cx43 (Figure 3a) . To analyse CCx43 translatability in living cells, we fused the GFP protein to the carboxyl terminus of human CCx43, since this approach has previously been successfully used to study the trafficking, assembly and function of Cx43 (Jordan et al., 1999; Laird et al., 2001) . After transfecting MCF-7 cells with the fusion constructs, we found that the CCx43-GFP chimera can be translated in vivo and form small aggregates, like the Cx43-GFP chimera and unlike the GFP protein alone (Figure 3b) .
Cx43 has been shown to have two functions which may be independent: growth control and GJIC (Moorby and Patel, 2001) . We thus stably transfected NIH/3T3 cells with a plasmid encoding the CCx43 ORF or the Cx43 counterpart. Using an MTT growth assay, we found that, like Cx43, the CCx43 product inhibits cell growth (Figure 4a ). In addition, both Cx43 and CCx43 inhibited colony formation in a soft agar assay (Figure 4b ). However, when assayed for the ability to mediate intercellular communication, expression of the CCx43 product had no effect ( Figure 5 ).
In addition to growth inhibition, it is also possible that the CCx43 transcript has an entirely different effect, independent of its translation into a protein. This effect could be exerted on other cell functions and maybe even on the Cx43 expression and function. A study suggested that transcribed pseudogenes are a potential source of a new class of regulatory genes, acting through an antisense mechanism (Korneev et al., 1999) . Recently, it was reported that a pseudogene can regulate the expression of the functional gene from which it originated (Hirotsune et al., 2003) . Whether the CCx43 mRNA has similar properties awaits further investigation.
If we assume the CCx43 translation product to be the active expression form, a careful analysis of the aminoacid sequence in the Cx43 and predicted CCx43 proteins (Figure 6 ) shows that differences lie along the whole sequence. Interestingly, out of the many changes found in the CCx43 sequence, few affect residues that have been cited in the literature as biologically important, namely residues S18, A40 and R202 (Paznekas et al., 2003) . Interestingly, the arginine R202 is changed into a cysteine in the pseudogene. Bearing in mind previous reports that the two Cx43 extracellular domains contain four cysteine residues which are able to interact by forming disulfide bonds (Foote et al., 1998) , it is possible that the additional cysteine, four residues away from the cysteine C198, might interfere with the disulfide interactions between the other four cysteines and thus affect pore formation and/or intercellular communication.
Although structure-function analysis of the Cx43 pseudogene product is beyond the scope of this paper, it is reasonable to speculate that this cysteine insertion could explain the observed GJIC inability of CCx43 ( Figure 5 ).
In summary, we found that the Cx43 processed pseudogene is transcribed selectively in human breast cancer cell lines versus normal cells. Although the high homology existing between Cx43 and CCx43 made it impossible for us to use the commercially available antibodies to unambiguously discriminate between the Cx43 protein and the CCx43 potential product, we showed by using in vitro translation and a GFP tag that CCx43 has the potential to be translated. We also found that the CCx43 product retains the growth-inhibitory function of the 'normal' Cx43 paralog. Nevertheless, many questions remain to be addressed in the future, mainly regarding the regulatory elements involved in the cancer cell-specific expression of CCx43 and the apparent paradox between this expression and the growth-inhibitory function of this pseudogene.
Materials and methods
Cell culture, selection and characterization of CCx43-overexpressing cells
The NIH/3T3 and MCF-7 cell lines (American Type Culture Collection (ATCC), Manassas, VA, USA) were maintained, respectively, in Dulbecco's modified minimal essential medium (DMEM) and RPMI-1640 (Life Technologies, Inc., Burlington, ON, USA) supplemented with 10% (v/v) fetal bovine serum (Life Technologies, Inc.), penicillin/streptomycin (100 mg/ml), (Life Technologies, Inc.) at 371C, in a humidified atmosphere containing 95% air and 5% CO 2 . Stable NIH/3T3 cell transfectants expressing CCx43 or Cx43 were generated by transfection, respectively, with a CCx43 or Cx43 cDNAencoding plasmid using the Lipofectamin kit (Invitrogen) and subsequent selection for G418 resistance. Transfectants were tested by RT-PCR for CCx43 and Cx43 expression, as will be described below.
Reverse transcription-PCR
RT-PCR was performed using the one-step RT-PCR kit (QIAGEN) according to the manufacturer's recommendations. Briefly, total RNA was isolated from cultured cells by the Trizol kit (Invitrogen). Total RNA (1 mg) was used for combined cDNA synthesis and PCR using Cx43-specific primers (Invitrogen). The RT-PCR reaction mixture contained the provided reaction buffer, 250 mM deoxynucleotide triphosphate, 50 pmol of each primer and 10 units of the reverse transcriptase/DNA polymerase enzyme mixture provided by the manufacturer. The PCR profile was 521C/30 min, 951C/15 min, followed by 32 cycles of: 941C/30 s, 571C/30 s and 721C/1 min, plus an additional extension at 721C/10 min. The amplification products were then digested or not with NcoI and separated on 1% agarose gel. The forward primer was 5 0 -ATGAGCAGTCTGCCTTTCGT-3 0 . The reverse primer was 5 0 -AAGGGTCGCTCTTTCCCTTA-3 0 . The amplified region encompassed nucleotides 140-739 from Cx43 and the equivalent region from CCx43. As an internal control, GAPDH (glyceraldehyde-phosphate dehydrogenase) primers were used to detect a 125 bp product, which were forward 5 0 -CCGGGAAACTGTGGCGTGAT-3 0 and reverse 5 0 -GAAGGCCATGCCAGTGAGCT-3 0 . Restriction enzyme digestions were repeated at least two times and with enzymes from different manufacturers to rule out variation in reaction to reaction digestion efficiency.
Cloning of the CCx43 pseudogene
Two oligonucleotides were designed to preferentially amplify the CCx43 putative ORF from genomic DNA from the human 293 cell line, which were: forward 5 0 -ATATGGATCCT-CACCTGGCGTGACTTCACTTCT-3 0 and reverse 5 0 -ATATCTCGAGTCCACAAGTGAGAGGAATCTTG-3 0 . BamHI and XhoI restriction sites were introduced in the forward and reverse sequences, respectively (Underlined). Using these primers, which are more homologous to the pseudogene sequence than to the Cx43 gene, and varying the annealing conditions, we were able to amplify the targeted sequence. PCR conditions were 951C/3 min, followed by 35 cycles of: 951C/30 s, 651C/2 min and 721C/2 min, plus an additional extension at 721C/10 min. The PCR product was digested with NcoI to confirm that it was amplified from the pseudogene and cloned into the BamHI and XhoI sites of the pcDNA3.1 vector (Invitrogen). The selected clone was labeled pCx43P and further verified by sequencing. A plasmid encoding the Cx43 cDNA was a generous gift from Dr Glenn I Fishman (New York University School of Medicine).
CCx43 promoter strength analysis
An EcoRV fragment including 2.3 kb of the region upstream of the ATG start codon of CCx43 was obtained using the Genome Walker kit (Clontech) according to the manufacturer's instructions. Two nested primers, designed based on the published human genome sequence (NCBI Accession M65189) were used for PCR amplification: GSP1, 5 0 -CAA CGA AAG GCA GAC TGC TCA TCT CC-3 0 , and GSP2, 5 0 -CTG ACT CGA GCA CTG TCT TCA GCA GCA GG-3 0 . A 1-kb fragment was amplified using the 2.3-kb EcoRV fragment as a template, and the primers 5 0 -TGA TCT TGG CTC ACT GCA AC-3 0 and 5 0 -GCA GCA GGA TTT GGA AAA TG-3 0 . The resulting PCR product cloned into pCR 2.1TOPO was then digested with KpnI and XhoI and cloned in the PGL3-basic vector (Promega). The Cx43 counterpart was obtained by subcloning a 1071 bp PCR-amplified fragment (using the primers: 5 0 -GGC TAA GGC AGG AGG ATT TC-3 0 and 5 0 -GAA AAG TAC TGA CGG CCA CAC C-3 0 ) from the promoter construct pCx2400luc (Carystinos et al., 2003) , into the PGL3-basic vector. Database searching was performed with BLASTN (Altschul et al., 1990) . All constructs were sequenced before use. Transfection of plasmids containing different inserts or the empty PGL-3 basic vector was done using the reagent lipofectamin according to the manufacturer (Invitrogen). Briefly, cells (4 Â 10 4 ) were seeded into 24-well plates and transfected by lipofectamin (Invitrogen), lysed 24 h thereafter and analysed for luciferase expression according to the manufacturer's directions (Promega) and using an EG&G Berthold Lumat LB 9507 luminometer.
Construction of chimeric connexin-GFP
To fuse CCx43 in frame to the amino terminus of GFP in the vector pEGFP-N2 (Clontech, Palo Alto, CA, USA), we amplified the CCx43 ORF by PCR from the pCx43P plasmid using the primers: forward 5 0 -GCAAAAGCTTGGTGCCCA-GGCAACATGCGTGACTG-3 0 and reverse 5 0 -CCTGGGG-CCCGATCTCCAGGTCATCAGGCTGAGGC-3 0 . In these primers, HindIII and ApaI sites were created at the 5 0 and 3 0 ends of the PCR product (Restriction sites underlined) and the CCx43 Stop codon (TAG) destroyed. The PCR products were digested with HindIII and ApaI and ligated into HindIII and ApaI site of pEGFP-N2. Competent DH5a Escherichia coli were then transformed with the ligation products and positive colonies were characterized. The selected fusion cDNA clone was further verified by sequencing (BioS&T). Cells (1 Â 10 5 ) were seeded on 16-mm 2 glass cover slips 1-2 days to reach confluence and transfected by the CCx43-GFP or Cx43-GFP (generous gift from Dr Dale Laird, University of Western Ontario) chimeric plasmids or the pEGFP-N2 empty vector using lipofectamin according to the manufacturer (GIBCO/ BRL). At 24 h after transfection, cells were fixed for 30 min in 4% paraformaldehyde. After washes in phosphate-buffered saline (PBS), the glass cover slips are mounted for microscope visualization.
Fluorescence microscopy
After transfection with the appropriate plasmids and fixation, localization of the fluorescent proteins was evaluated with an Olympus BX51 microscope equipped with a filter set for fluorescein and rhodamine.
Cell-free translation
Coding regions of Cx43 and CCx43 and a control pcDNA3.1 vector were transcribed and translated in vitro with T7 polymerase using the reticulocyte lysate-based TNT Quick Coupled Transcription/Translation Systems Kit (Promega) following the manufacturer's protocol. DNA (1-2 mg) was used as template in the presence of 20 mCi of [
35 S]methionine (ICN), and incubated at 301C for 90 min. The translation products were analysed by SDS-PAGE and gels were fixed and dried before exposure to X-ray films at À701C overnight.
MTT and colony formation assays
For the MTT assay, exponentially growing cells (2 Â 10 3 per 200 ml per well) were seeded in 96-well plates and were grown for 1-4 days. Cell survival was evaluated by replacing the culture media by 50 ml of 2.5 mg/ml MTT (Sigma, St Louis, MO, USA), in PBS(pH 7.5). After 4 h of incubation at 371C in the dark, MTT was removed and 100 ml of solubilization solution (10% Triton 100 Â , and 1 N HCl in anhydrous isopropanol) were added. The absorbance was determined at 570 nm with a microplate reader (Biorad).
For the colony formation assay, 2 Â 10 3 cells were initially seeded into six-well plates with top and bottom layers of 0.3 and 0.6% agar, respectively, containing culture medium and cultured for 2-3 weeks. This was repeated in three separate experiments.
Scrape-loading/dye transfer assay GJIC was monitored as previously described (El-Fouly et al., 1987; Venance et al., 1995) with minor modifications. Briefly, cells were grown in six-well plates. After rinsing with PBS, a mixture of 1% LY (Molecular Probes) and 1% of RD (Molecular Probes) in PBS was added. The cell layer was then scratched by applying a 26-gauge needle. After exactly 3 min incubation in the dye mixture, the cells are rinsed three times with PBS. Cells are fixed for 20 min at room temperature with 4% paraformaldehyde/PBS (pH 7.5) and washed three times with PBS. LY and RD were observed by fluorescence microscopy (Olympus BX51) using fluorescein and rhodamine filter sets, respectively.
Statistical analysis
Luciferase assay and MTT assay Results are presented as the mean7s.d. (standard deviation) of experiments performed in triplicate. P-values were calculated using the t-test. Differences were considered significant (*) if Po0.05.
